C. Werely

发表

Isoniazid pharmacokinetics in children treated for respiratory tuberculosis

P. V. van Helden, P. Donald, J. Maritz, 2005, Archives of Disease in Childhood.

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

P. V. Helden, P. Donald, F. Sirgel, 2007, European Journal of Clinical Pharmacology.

An Unexpectedly Complex Architecture for Skin Pigmentation in Africans

Elizabeth G. Atkinson, Christopher R. Gignoux, Alicia R. Martin, 2017, Cell.

DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma

P. V. van Helden, C. Werely, C. Heyns, 1996, Genes, chromosomes & cancer.

Isoniazid Pharmacokinetics, Pharmacodynamics, and Dosing in South African Infants

S. Madhi, C. Fletcher, V. Carey, 2012, Therapeutic drug monitoring.

Allele Frequencies for Glutathione S-Transferase and N-Acetyltransferase 2 Differ in African Population Groups and May Be Associated With Oesophageal Cancer or Tuberculosis Incidence

P. D. Helden, E. Hoal, C. Werely, 2003, Clinical chemistry and laboratory medicine.

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.

G. Hussey, P. Donald, H. McIlleron, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Isoniazid in Low-Birth-Weight and Premature Infants

M. Cotton, C. Werely, H. Draper, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Isoniazid, Rifampin, and Pyrazinamide in Children Younger than Two Years of Age with Tuberculosis: Evidence for Implementation of Revised World Health Organization Recommendations

S. Roll, P. Donald, K. Magdorf, 2011, Antimicrobial Agents and Chemotherapy.

Isoniazid The Pharmacogenetics of NAT 2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving

C. Werely, D. D’Argenio, J. Kiser, 2011 .

Pyridoxal‐5‐phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid

D. Labadarios, G. Hussey, P. Donald, 2010, Acta paediatrica.

Epidemiological correlates of overweight and obesity in the Northern Cape Province, South Africa

M. H. Smith, B. Henn, Austin W. Reynolds, 2022, medRxiv.

N-Acetyltransferase Genotypes and the Pharmacokinetics and Tolerability of para-Aminosalicylic Acid in Patients with Drug-Resistant Pulmonary Tuberculosis

A. Diacon, L. van der Merwe, P. Donald, 2015, Antimicrobial Agents and Chemotherapy.

The glycosaminoglycans of the gubernaculum during testicular descent in the fetus.

C. Werely, C. Heyns, H. Human, 1990, The Journal of urology.

Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations

C. Werely, 2012 .

Structural and functional effects of nucleotide variation on the human TB drug metabolizing enzyme arylamine N-acetyltransferase 1.

A. Christoffels, P. V. van Helden, C. Werely, 2017, Journal of molecular graphics & modelling.

Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa

Christopher R. Gignoux, P. Parham, B. Henn, 2018, Journal of Immunology.

NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patients.

P. V. van Helden, P. Donald, C. Werely, 2007, Personalized medicine.

The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid.

P. V. van Helden, P. Donald, F. Sirgel, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oligonucleotide (GTG)5 as a marker for Mycobacterium tuberculosis strain identification

P. V. van Helden, N. Beyers, P. Donald, 1994, Journal of clinical microbiology.

The collagen content of the gubernaculum during testicular descent in the pig fetus.

C. Werely, C. Heyns, C. Heyns, 1989, Journal of anatomy.

Acquired drug resistance during inadequate therapy in a young child with tuberculosis.

P. Donald, A. Garcia-Prats, C. Werely, 2014, The Pediatric infectious disease journal.

NAT2 slow acetylator function as a risk indicator for age-related cataract formation.

P. V. van Helden, D. Parkin, C. Werely, 2003, Pharmacogenetics.

The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid

C. Fletcher, C. Werely, D. D’Argenio, 2012, Journal of clinical pharmacology.

Slave Trade and Colonial Expansion Resulted in Strong Sex-Biased Admixture in South Africa

S. Gravel, B. Henn, P. V. van Helden, 2023, bioRxiv.

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.

G. Hussey, P. Donald, H. McIlleron, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Structural and functional effects of nucleotide variation on the human TB drug metabolizing enzyme arylamine N-acetyltransferase 1.

W. A. Akurugu, A. Christoffels, P. V. van Helden, 2017, Journal of molecular graphics & modelling.